These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 31711946)

  • 1. Comparison of early type 2 diabetes improvement after gastric bypass and sleeve gastrectomy: medication cessation at discharge predicts 1-year outcomes.
    Heshmati K; Harris DA; Aliakbarian H; Tavakkoli A; Sheu EG
    Surg Obes Relat Dis; 2019 Dec; 15(12):2025-2032. PubMed ID: 31711946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleeve gastrectomy and Roux-en-Y gastric bypass in the treatment of type 2 diabetes. Two-year results from a Swedish multicenter randomized controlled trial.
    Wallenius V; Alaraj A; Björnfot N; Orrenius B; Kylebäck A; Björklund P; Werling M; Thorell A; Fändriks L; Maleckas A
    Surg Obes Relat Dis; 2020 Aug; 16(8):1035-1044. PubMed ID: 32540150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of 1-year outcomes between Roux-en-Y gastric bypass and sleeve gastrectomy with Roux-en-Y duodenojejunal bypass in the patients of obesity with type 2 diabetes mellitus].
    Liang H; Si YM; Lin SB; Shen JJ; Guan W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Nov; 26(11):1051-1057. PubMed ID: 37974350
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic effects of bariatric surgery on patients with type 2 diabetes: a population-based study.
    Akpinar EO; Liem RSL; Nienhuijs SW; Greve JWM; Marang-van de Mheen PJ;
    Surg Obes Relat Dis; 2021 Jul; 17(7):1349-1358. PubMed ID: 33762128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loop versus Roux-en-Y duodenojejunal bypass with sleeve gastrectomy for type 2 diabetes: short-term outcomes of a single-center randomized controlled trial.
    Lin S; Li C; Shen J; Guan W; Liang H
    Surg Obes Relat Dis; 2022 Nov; 18(11):1277-1285. PubMed ID: 35985975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Safety and Effectiveness of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy for Weight Loss and Type 2 Diabetes Across Race and Ethnicity in the PCORnet Bariatric Study Cohort.
    Coleman KJ; Wellman R; Fitzpatrick SL; Conroy MB; Hlavin C; Lewis KH; Coley RY; McTigue KM; Tobin JN; McBride CL; Desai JR; Clark JM; Toh S; Sturtevant JL; Horgan CE; Duke MC; Williams N; Anau J; Horberg MA; Michalsky MP; Cook AJ; Arterburn DE; Apovian CM;
    JAMA Surg; 2022 Oct; 157(10):897-906. PubMed ID: 36044239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Weight Loss Results, Remission of Comorbidities and Nutritional Deficiencies of Sleeve Gastrectomy (SG), Roux-En-Y Gastric Bypass (RYGB) and One-Anastomosis Gastric Bypass (OAGB) on Type 2 Diabetic (T2D) Patients.
    Castro MJ; Jimenez JM; Carbajo MA; Lopez M; Cao MJ; Garcia S; Ruiz-Tovar J
    Int J Environ Res Public Health; 2020 Oct; 17(20):. PubMed ID: 33092117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of diabetes, gastrointestinal symptoms, and self-reported dietary intake after gastric bypass versus sleeve gastrectomy: a randomized study.
    Laurenius A; Wallengren O; Alaraj A; Forslund HB; Thorell A; Wallenius V; Maleckas A
    Surg Obes Relat Dis; 2023 May; 19(5):440-448. PubMed ID: 36443214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of weight loss outcomes between Roux-en-Y gastric bypass and sleeve gastrectomy in a racially mixed urban patient population.
    Ju Z; Anderson W; Istfan N; Carmine B; Carter C; Pernar L; Marshall A; Hess DT
    Surg Obes Relat Dis; 2022 Oct; 18(10):1218-1227. PubMed ID: 35794035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of bariatric surgery on insulin-treated type 2 diabetes patients.
    Lemus R; Karni D; Hong D; Gmora S; Breau R; Anvari M
    Surg Endosc; 2018 Feb; 32(2):990-1001. PubMed ID: 28842774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of sleeve gastrectomy on type 2 diabetes as an alternative treatment modality to Roux-en-Y gastric bypass: systemic review and meta-analysis.
    Cho JM; Kim HJ; Lo Menzo E; Park S; Szomstein S; Rosenthal RJ
    Surg Obes Relat Dis; 2015; 11(6):1273-80. PubMed ID: 26071847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the 1-year curative efficacy of sleeve gastrectomy, Roux-en-Y gastric bypass, single anastomosis duodenal-ileal bypass with sleeve gastrectomy and biliopancreatic diversion with duodenal switch in patients with super obesity].
    Zhang Z; Wang L; Zhao YH; Jiang T; Zhang ZZ; Wang X; Hu LF; Xiao MH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Sep; 26(9):859-865. PubMed ID: 37709694
    [No Abstract]   [Full Text] [Related]  

  • 13. Ten-year outcomes after Roux-en-Y gastric bypass and sleeve gastrectomy: an observational nonrandomized cohort study.
    Jiménez A; Ibarzabal A; Moizé V; Pané A; Andreu A; Molero J; de Hollanda A; Flores L; Ortega E; Lacy A; Vidal J
    Surg Obes Relat Dis; 2019 Mar; 15(3):382-388. PubMed ID: 30772254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seven-year trajectories of body weight, quality of life and comorbidities following Roux-en-Y gastric bypass and sleeve gastrectomy.
    Nielsen HJ; Nedrebø BG; Fosså A; Andersen JR; Assmus J; Dagsland VH; Dankel SN; Gudbrandsen OA; Fernø J; Hjellestad I; Hjermstad MJ; Kolotkin RL; Thorsen HL; Mellgren G; Flølo TN
    Int J Obes (Lond); 2022 Apr; 46(4):739-749. PubMed ID: 34974544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ghrelin, leptin, and glycemic control after sleeve gastrectomy versus Roux-en-Y gastric bypass-results of a randomized clinical trial.
    Kalinowski P; Paluszkiewicz R; Wróblewski T; Remiszewski P; Grodzicki M; Bartoszewicz Z; Krawczyk M
    Surg Obes Relat Dis; 2017 Feb; 13(2):181-188. PubMed ID: 27692906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bariatric procedure selection in patients with type 2 diabetes: choice between Roux-en-Y gastric bypass or sleeve gastrectomy.
    Aminian A
    Surg Obes Relat Dis; 2020 Feb; 16(2):332-339. PubMed ID: 31902579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thirty-day outcomes of sleeve gastrectomy versus Roux-en-Y gastric bypass: first report based on Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database.
    Chaar ME; Lundberg P; Stoltzfus J
    Surg Obes Relat Dis; 2018 May; 14(5):545-551. PubMed ID: 29551470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of metabolic outcomes in patients undergoing laparoscopic roux-en-Y gastric bypass versus sleeve gastrectomy - a systematic review and meta-analysis of randomised controlled trials.
    Hayoz C; Hermann T; Raptis DA; Brönnimann A; Peterli R; Zuber M
    Swiss Med Wkly; 2018; 148():w14633. PubMed ID: 30035801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved acylated ghrelin suppression at 2 years in obese patients with type 2 diabetes: effects of bariatric surgery vs standard medical therapy.
    Malin SK; Samat A; Wolski K; Abood B; Pothier CE; Bhatt DL; Nissen S; Brethauer SA; Schauer PR; Kirwan JP; Kashyap SR
    Int J Obes (Lond); 2014 Mar; 38(3):364-70. PubMed ID: 24166065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight Loss After Sleeve Gastrectomy: Does Type 2 Diabetes Status Impact Weight and Body Composition Trajectories?
    Diedisheim M; Poitou C; Genser L; Amouyal C; Bouillot JL; Ciangura C; Oppert JM; Clément K; Aron-Wisnewsky J
    Obes Surg; 2021 Mar; 31(3):1046-1054. PubMed ID: 33146869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.